TY  - GEN
AU  - Kantarjian,H M
AU  - Talpaz,M
AU  - Kontoyiannis,D
AU  - Gutterman,J
AU  - Keating,M J
AU  - Estey,E H
AU  - O'Brien,S
AU  - Rios,M B
AU  - Beran,M
AU  - Deisseroth,A
TI  - Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor
SN  - 0732-183X
PY  - 1992///0325
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Blast Crisis
KW  - drug therapy
KW  - Bone Marrow Diseases
KW  - chemically induced
KW  - Cytarabine
KW  - administration & dosage
KW  - Daunorubicin
KW  - Granulocyte-Macrophage Colony-Stimulating Factor
KW  - therapeutic use
KW  - Humans
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - Leukemia, Myeloid, Accelerated Phase
KW  - Middle Aged
KW  - Prognosis
KW  - Remission Induction
KW  - Survival Analysis
N1  - Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1200/JCO.1992.10.3.398
ER  -